GRP78 is commonly overexpressed in cancer and confers therapeutic resistance with its protective effect not only observed in proliferating cancer cells but also in dormant cancer cells, tumor-initiating cells as well as tumor-supporting stroma cells (29, –31). Here, HSPA5 is linked to neoplasm.